<DOC>
	<DOCNO>NCT00002362</DOCNO>
	<brief_summary>This study look whether emtricitabine safe effective abacavir ( ABC ) take stavudine ( d4T ) efavirenz ( EFV ) patient never take anti-HIV drug .</brief_summary>
	<brief_title>A Comparison Emtricitabine Abacavir Used Three-Drug Combination HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs</brief_title>
	<detailed_description>Patients randomize receive open-label emtricitabine ABC combination stavudine efavirenz . Viral load CD4+ cell count compare Weeks 24 48 . Patients follow 48 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>Inclusion Criteria You may eligible : Are HIVpositive generally healthy . Have viral load 5,000 copies/ml . Have CD4 cell count 200 cells/mm3 . Are age 18 older . Agree practice sexual abstinence use effective barrier method birth control ( condom ) . Exclusion Criteria You eligible : Have ever take antiHIV drug 3 day . Have certain AIDSrelated infection . Have severe diarrhea within past 30 day . Are unable eat least 1 meal day due nausea , vomit , stomach pain . Are treat active tuberculosis ( TB ) . Are pregnant breastfeeding . Use illegal drug alcohol make difficult take study drug keep clinic appointment . Are take certain medication , certain condition disease ( see technical summary detail ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2000</verification_date>
	<keyword>Dideoxynucleosides</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Stavudine</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>abacavir</keyword>
	<keyword>efavirenz</keyword>
</DOC>